ArticleFrontiers in pharmacology2021

A Randomized, Double-Blind, Single-Dose Study Comparing the Biosimilarity of HOT-1010 With Bevacizumab (Avastin®) in Chinese Healthy Male Subjects.

Kai Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.